Development of programs to predict the occurrence of mucositis from digital imaging and communications in medicine data by machine learning in head and neck volumetric modulated radiotherapy
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning accurately predicts severe mucositis in head and neck cancer patients undergoing VMAT with cisplatin. This predictive tool aids in preventing treatment delays and supports early intervention for radiotherapy patients.
Area Of Science
- Oncology
- Medical Physics
- Radiotherapy
Background
- Head and neck cancer patients treated with VMAT and cisplatin often develop severe mucositis.
- Current management lacks standardized prevention and treatment protocols for mucositis.
- Adaptive radiotherapy (ART) is used for severe mucositis but requires re-planning during treatment.
Purpose Of The Study
- To develop a machine learning program for predicting mucositis requiring ART in head and neck cancer patients.
- To identify quantitative features from treatment plans associated with severe mucositis development.
Main Methods
- Retrospective analysis of treatment plans (DICOM data) from 61 patients receiving concurrent chemotherapy and radiotherapy (RT).
- Extraction of quantitative features including equivalent square field size, dose per segment, clinical target volume, and mean oral cavity dose.
- Application of Support Vector Machine (SVM) and K-nearest neighbor (KNN) algorithms for machine learning classification.
Main Results
- Machine learning models (SVM and KNN) achieved high accuracy (0.981 ± 0.020 and 0.972 ± 0.033, respectively) in classifying the need for ART due to mucositis.
- The developed program accurately predicted the onset of mucositis requiring ART before treatment initiation.
- Classification of a five-dimensional data list was achieved with high accuracy.
Conclusions
- A novel machine learning program can accurately predict mucositis requiring ART in head and neck cancer patients.
- This predictive capability may facilitate early preventive measures and ensure uninterrupted radiotherapy completion.
- The study supports the potential for proactive management of radiotherapy-induced mucositis.

